Life Sciences Real Estate Faces a Cooling Cycle

October 27, 2025

For several years, lab space was one of the most sought-after areas in commercial real estate, fueled by strong biotech and pharmaceutical growth. Developers rapidly converted offices into laboratory facilities across major markets like Boston, San Diego, and Silicon Valley, expecting sustained tenant demand. That boom is now losing steam. Vacancy rates in life sciences buildings have climbed to roughly 27 percent, and some newly completed properties remain nearly half empty as leasing momentum slows.

The slowdown stems from several converging factors. Federal research budgets have declined by about five billion dollars compared with prior years, while venture capital investment in life sciences is on track to hit its lowest level since the pandemic. After years of aggressive development, many markets are now oversupplied just as funding and tenant expansion have cooled.

As a result, some landlords and developers are exploring ways to repurpose lab buildings into data centers, AI infrastructure, or light manufacturing facilities. The shift marks a broader adjustment within commercial real estate, where even high-demand specialty sectors are rebalancing after an extended period of rapid growth.

(Source: Business Insider, October 2025)